Erectile dysfunction: When tablets don't work

Australian Family Physician

Volumn 39, Issue 5, 2010, Pages 301-305

  Smith, Ian A R ^a,b,c   McLeod, Nicholas ^d   Rashid, Prem ^e  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d PORT MACQUARIE BASE HOSPITAL   (Australia)

^e University of New South Wales Rural Clinical School   (Australia)

Author keywords

Erectile dysfunction; Men's health

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; TESTOSTERONE; VASODILATOR AGENT;

ADULT; ARTICLE; AUSTRALIA; DRUG EFFECT; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PENIS ERECTION; PENIS PROSTHESIS; RISK ASSESSMENT; TREATMENT OUTCOME; DRUG EFFECTS;

ADMINISTRATION, ORAL; ADULT; AUSTRALIA; ERECTILE DYSFUNCTION; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; PENILE ERECTION; PENILE PROSTHESIS; PHOSPHODIESTERASE INHIBITORS; RISK ASSESSMENT; TESTOSTERONE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 77957235804     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83-90.
2. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000;12(Suppl 4):S6-11.
3. Chew KK, Stuckey B, Bremner A, et al. Male erectile dysfunction: its prevalence in Western Australia and associated sociodemographic factors. J Sex Med 2008;5:60-9.
4. Bacon CG, Mittleman MA, Kawachi I, et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003;139:161-8.
5. Andrology Australia. Erectile dysfunction: diagnosis and management. GP summary guide 9, July 2007. Available at www.andrologyaustralia.org.
6. Rosenberg MT. Diagnosis and management of erectile dysfunction in the primary care setting. Int J Clin Pract 2007;61:1198-208.
7. McVary KT. Clinical practice. Erectile dysfunction. N Engl J Med 2007;357:2472-81.
8. S habsigh R, Arver S, Channer KS, et al. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract 2008;62:791-8.
9. Makhlouf A, Kparker A, Niederberger CS. Depression and erectile dysfunction. Urol Clin North Am 2007;34:565-74.
10. Steggall MJ. Erectile dysfunction: physiology, causes and patient management. Nurs Stand 2007;21:49-56.
11. Ellsworth P, Kirshenbaum EM. Current concepts in the evaluation and management of erectile dysfunction. Urol Nurs 2008;28:357-69.
12. Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005;96:85-93M.
13. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-26.
14. Rosen RC, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-30.
15. Sexual Health Inventory for Men (SHIM). Available at www.rohbaltimore.com/SHIM.pdf.
16. International Prostate Symptom Score Sheet (IPSS). Available at www.gp-training.net/protocol/docs/ipss.doc.
17. Fink HA, MacDonald R, Rutks IR, et al. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2002;162:1349-60.
18. Padma-Nathan H, Stecher VJ, Sweeney M, et al. Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial. Urology 2003;62:400-3.
19. Kendirci M, Tanriverdi O, Trost L, et al. Management of sildenafil treatment failures. Curr Opin Urol 2006;16:449-59.
20. Sivalingam S, Hashim H, Schwaibold H. An overview of the diagnosis and treatment of erectile dysfunction. Drugs 2006;66:2339-55.
21. Brant WO, Bella AJ, Lue TF. Treatment options for erectile dysfunction. Endocrinol Metab Clin North Am 2007;36:465-79.
22. Montorsi F, Salonia A, Zanoni M, et al. Current status of local penile therapy. Int J Impot Res 2002;14(Suppl 1):S70-81.
23. Urciuoli R, Cantisani TA, Carlinil M, et al. Prostaglandin E1 for treatment of erectile dysfunction. Cochrane Database Syst Rev 2004; Issue 2: Art. No. CD001784.
24. Seyam R, Mohamed K, Akhras AA, et al. A prospective randomized study to optimize the dosage of Trimix ingredients and compare its efficacy and safety with prostaglandin E1. Int J Impot Res 2005;17:346-53.
25. Gurbuz N, Mammadov E, Usta MF. Hypogonadism and erectile dysfunction: an overview. Asian J Androl 2008;10:36-43.
26. Sadeghi-Nejad H. Penile prosthesis surgery: a review of prosthetic devices and associated complications. J Sex Med 2007;4:296-309.
27. Henry GD, Wilson SK. Updates in inflatable penile prostheses. Urol Clin North Am 2007;34:535-47.
28. Mulhall JP. Penile rehabilitation following radical prostatectomy. Curr Opin Urol 2008;18:613-20.